China SXT PharmaceuticalsSXTC
SXTC
About: China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
Employees: 75
0
Funds holding %
of 6,740 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
2,409% more capital invested
Capital invested by funds: $3.19K [Q1] → $79.9K (+$76.8K) [Q2]
75% more funds holding
Funds holding: 4 [Q1] → 7 (+3) [Q2]
12.37% more ownership
Funds ownership: 0.5% [Q1] → 12.87% (+12.37%) [Q2]
Research analyst outlook
We haven’t received any recent analyst ratings for SXTC.
Financial journalist opinion
Charts implemented using Lightweight Charts™